Does AVELUMAB Cause Second primary malignancy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with AVELUMAB (BAVENCIO). This represents 0.1% of all adverse event reports for AVELUMAB.
5
Reports of Second primary malignancy with AVELUMAB
0.1%
of all AVELUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Second primary malignancy From AVELUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVELUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AVELUMAB Cause?
Death (361)
Disease progression (355)
Off label use (200)
Diarrhoea (153)
Infusion related reaction (142)
Pyrexia (129)
Fatigue (124)
Neoplasm progression (119)
Dyspnoea (100)
Nausea (99)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which AVELUMAB Alternatives Have Lower Second primary malignancy Risk?
AVELUMAB vs AVIBACTAM
AVELUMAB vs AVIBACTAM\CEFTAZIDIME
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE
AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE